Analysis

Today's release of BioNTech's full-year 2025 financials is drawing investor attention away from quarterly earnings and toward the company's evolving...

The pharmaceutical sector is bracing for potential margin compression after Novo Nordisk signaled aggressive price reductions for its blockbuster GLP-1...

The digital advertising sector is undergoing a significant transformation, and The Trade Desk is positioning itself at the forefront of...

All eyes will be on Fiserv CEO Mike Lyons tomorrow as he takes the stage at the Wolfe Fintech Forum....

A major legal overhang for the telehealth company Hims & Hers has been decisively removed, sending its shares skyrocketing. The...

D-Wave Quantum Inc. presents a complex investment case, defined by a stark contrast between its recent financial performance and a...

A notable surge in institutional investment is signaling strong market confidence in Gilead Sciences. The biopharmaceutical giant is attracting significant...

Investor attention within the biotechnology space is increasingly focused on Outlook Therapeutics. The company is approaching several pivotal operational milestones...

Alphabet Inc. finds itself at the center of two significant corporate developments this week, each highlighting distinct facets of the...

Navitas Semiconductor Corporation is undertaking a fundamental strategic overhaul, shifting its entire focus toward artificial intelligence infrastructure. This move away...